It is interview season for medical fellowships and I thought I would take the time to discuss some of the issues I see come up recurrently in evaluating applicants, especially in dedicated physician-scientist research programs.
I am fortunate to have graduated from @UCLA ’s STAR program which feel is an incredible model for training physician-scientists.
Most MD-PhD programs in the U.S. are funded by the @NIH MSTP program which integrate research and medical education. MSTP funds 50 programs and supports ~1000 trainees annually. nigms.nih.gov/training/instp…
The problem with the MSTP model is the attrition of trainees into non-research careers. For a costly federally-funded training program, planting seeds that do not fruit is a problem.
It’s a very long road from medical school, graduate work, clinical training to starting up your own research program. Frequently, methods learned during MSTP are now dated across disciplines.
The STAR Program flips the model to terminate both clinical and PhD training at the terminal clinical program. We believe this allows physician-scientists to take on the issues in translational/medical research that will further advanced the field.
medschool.ucla.edu/star-about-star
First 20 year outcomes with @ucla STAR program here:
ncbi.nlm.nih.gov/pmc/articles/P…
Other programs obviously train many physician-scientists without following UCLA's model or encouraging PhD degrees to do outcomes or health services research.
Ultimately the strength of a training programs is based on mentors/mentorship and supporting fellows/faculty through their early career years.
The first important lesson for potential applicants is to learn and work with individuals that are physician-scientists at your institution. With the limited time you have, try to get involved with research projects that you may lead with considerable mentorship support.
Ask mentors to describe their physician-scientist career and how they do their work. Observe them. When you hear PIs grumble about academic research, you’ll quickly learn that grants are a prominent component of career advancement.
Across all disciplines, PIs write: grants, manuscripts, peer-review evaluations, protocols, IRBs while trying to also find time to actually get the work done and break through the practical challenges of research.
Generally PIs spend 75%-80% of their academic time doing research. Some remarkable individuals balance 50/50, but this model is usually reserved for proceduralists surgeons, interventionalists, etc. that require more clinical exposure to maintain procedural competency.
Before applying for physician-scientists training programs, you must have a fairly good understanding of what the career requires and the time investment.
It’s a very long road for even the UCLA STAR fellows. The expectation is that the university is investing nearly 5-10 on the fellowship/early career transition to create independent investigators.
In this courtship between applicant and institution, we form a long-term relationship (much like a marriage). A single-day interviewing with 5-8 faculty is a very hard way to decide who is the most qualified and best fit. Even paper applications tend to look very similar.
As an applicant you should research the program you are applying for and get to know the faculty bios of individuals you may hope to work with. It is helpful to have a rough idea of the area of research/large healthcare problem you see yourself building a career around.
If a program seems like a good fit for your career aspirations, make it known. Write emails or have additional conversations with people at the program about why you feel you would thrive in the environment and achieve your career goals.
Take the opportunity to speak with current fellows, early career faculty, senior faculty, etc. Especially if those conversations were cut short or not available on interview day.
I recall being an applicant and being fairly naïve about the entire application/career process and I continue to learn more about what it takes to achieve my goals and generate meaningful work in my field.
My last endorsement is for seeking out multiple mentors throughout one’s career that are at various stages above you. Multiple perspectives also help navigate advice that isn’t always the truth. Myself and this thread are no exceptions.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Boback Ziaeian 🤦🏻‍♂️

Boback Ziaeian 🤦🏻‍♂️ Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @boback

15 Jun
The Pandemic Claims New Victims: Prestigious Medical Journals via @NYTimes@RoniNYTimesnytimes.com/2020/06/14/hea…
“‘We do tend to trust our authors,” Dr. Rubin said. “All journals do.” Both editors pointed out that Dr. Mehra had signed statements indicating he had access to all of the data and took responsibility for the work, as did other co-authors.”
Read 6 tweets
3 Jun
How did Surgisphere generate the publication data?
To simulate each observation (n=96,032) he'd have to know how to distribute all the characteristics and adjust them as needed.
To falsify tables, he'd have to account for counts carefully and generate confidence intervals and other statistics as a best guess from other papers while making sure things were fairly consistent.
Read 4 tweets
2 Jun
@mikejohansenmd @NEJM @TheLancet There is more evidence of falsification with this figure. @ADAlthousePhD will provide more details in the morning on the variance estimates.
@mikejohansenmd @NEJM @TheLancet @ADAlthousePhD Now look at the reference group 0-10: the figure claims that 11-20 and 21-30 year-olds have a lower risk of death relative to kids <10. Well if that’s true it should be the headline of the @NEJM study.
@mikejohansenmd @NEJM @TheLancet @ADAlthousePhD The odds ratio for the risk of death relative to kids <10 to those over 80 should be like 200x the OR not ~5.
Read 5 tweets
30 May
Let me take us all on a magical walk through the @Surgisphere "revision" and explanation given to the @lancet. Not everything looks like what it seems. I would hope @richardhorton1 would have pushed for better explanations.
Let us start with the correction statement. One hospital from Australia should have been in Asia. Not sure why a hospital a company sold a product to would need to self-identify for a cloud-based data analytics platform:
They also notify us that the original table S3 was corrected and the lack of variation was because they presented "propensity matched and weighted" tables rather than raw estimates.
Read 33 tweets
13 May
Estimating the burden of SARS-CoV-2 in France science.sciencemag.org/content/early/… @ScienceMagazine
"The overall probability of death among those infected (the Infec-tion Fatality Ratio, IFR) is 0.7% (95% CrI: 0.4–1.0), ranging from 0.001% in those under 20ya to 10.1% (95% CrI: 6.0–15.6) in those >80ya (Fig. 2D and table S2)."
"We find that the basic repro-ductive number R0 prior to the implementation of the lock-down was 2.90 (95% CrI: 2.80–2.99). The lockdown resulted in a 77% (95% CI: 76–78) reduction in transmission, with the reproduction number R dropping to 0.67 (95% CrI: 0.65–0.68)."
Read 9 tweets
22 Apr
This is a thread about the @stanford research group that has led the Santa Clara/Los Angeles @lapublichealth serology studies. I want to highlight the importance of content expertise and biases of personal beliefs.
Who was involved in these studies and how were they performed?
Links to pre-prints:
medrxiv.org/content/10.110…

The second seemed to be leaked on @RedState than removed.
dropbox.com/s/pk7nu9gz0vhg…
The Santa Clara study was led by corresponding author Eran Bendavid and Jay Bhattacharya from @StanfordMed .

Dr. Bendavid is an MD in infectious diseases with master's in health services research. His prior work was in global child health (not pandemic related)
Read 24 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!